Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

70.35 -0.13 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dexcom Inc

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
The Best Stocks to Invest $20,000 in Right Now
The market is ripe with opportunity. 
Via The Motley Fool
3 Supercharged Growth Stocks to Buy for 2023
Next year could be a very important one for all three of these fast-growing businesses. 
Via The Motley Fool
Is This Stock-Split Stock a Buy For 2023?
Don't buy this company's shares for its recent stock split. 
Via The Motley Fool
Stock Market Investing Action Plan: What Part Of November Don't You Understand?
A turnabout month left the market sitting on some nice gains. The next week's data might determine whether those gains hold. 
Via Investor's Business Daily
Dexcom Leads 5 Stocks Near Buy Points
They combine strong technicals and generally sound fundamentals. 
Via Investor's Business Daily
Is It Too Late to Buy DexCom Stock?
The shares have been surging after the medical device specialist released its latest earnings report. 
Via The Motley Fool
DexCom Stock: Bull vs. Bear
The diabetes care technology leader has a huge opportunity. But its valuation could be an issue. 
Via The Motley Fool
Why DexCom Stock Is Soaring Today
Investors loved the company's third-quarter update. 
Via The Motley Fool
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
2 Unstoppable Growth Stocks to Buy in 2022 and Beyond
Don't let the current market keep you from putting spare cash to work in great companies. 
Via The Motley Fool
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023. 
Via MarketBeat
Topics Stocks
Exposures US Equities
3 No-Brainer Growth Stocks to Buy for 2023 and Beyond
No-brainer growth stocks to buy for 2023 and beyond are companies that are growing their top and bottom lines and piling up the cash. 
Via InvestorPlace
Golden Cross Appears Before DexCom Investors
If history is any guide, there may be good fortune ahead for shares of DexCom (NASDAQ:DXCM). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the... 
Via Benzinga
Expert Ratings for DexCom
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following analyst ratings: 
Via Benzinga
DexCom (DXCM) Q3 2022 Earnings Call Transcript
DXCM earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Got $2,000? 2 Fantastic Stocks to Buy No Matter What the Market Does Next
These stocks both have non-cyclical businesses that can drive growth in a wide variety of markets. 
Via The Motley Fool
Got $1,000? 2 Bear Market Stocks to Jump On Right Now
Regardless of what the market does next, these top stocks have a much longer growth trajectory ahead. 
Via The Motley Fool
2 Reasons to Buy DexCom, and 1 Reason to Sell
Do the potential benefits outweigh the risks? 
Via The Motley Fool
CapitalGainsReport Sector Spotlight: Wearable Health (DXCM, WHSI, IRTC, BTCY)
Via AB Newswire
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stock-Split Stocks That Are Crushing the Bear Market of Late
These widely held stock-split stocks put the bear market in its place by respectively gaining 27% and 50% in October. 
Via The Motley Fool
2 Growth Stocks That Are Soaring: Are They Buys?
Both companies are still down over the past year, but they were on fire in October. 
Via The Motley Fool
DexCom's Return On Capital Employed Insights
According to Benzinga Pro, during Q3, DexCom (NASDAQ:DXCM) earned $101.20 million, a 98.82% increase from the preceding quarter. DexCom also posted a total of $769.60 million in sales, a 11.18%... 
Via Benzinga
Is DexCom a Good Healthcare Stock to Buy Now?
After rising about 50% in October, investors want to know if this stock still has any fuel in the tank. 
Via The Motley Fool
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
From DexCom, Inc.
Via Business Wire
7 Stocks Billionaires are Buying Now
Even as markets have plunged, billionaires have been buying beaten down names. All well aware that market pullbacks are buy opportunities. 
Via InvestorPlace
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Apple, Intel, And Some Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Nuvalent (NASDAQ:NUVL) stock increased by 15.9% to $25.5 during Friday's pre-market session. The company's market cap stands at $1.2 billion. 
Via Benzinga
Why DexCom Stock Is Rising After Hours
DexCom Inc (NASDAQ: DXCM) shares are trading higher in Thursday's after-hours session after the company reported better-than-expected  
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback